Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04792281

Impact of FDG-PET/CT on Management of Patients with Native Valve Infective Endocarditis

Status
Recruiting
Phase
Study type
Observational
Enrollment
97 (estimated)
Sponsor
Montreal Heart Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The proposed study is a multicentric prospective observational cohort study of patients with suspected NVE. The study population includes those with Possible IE according to the modified Duke criteria and investigated at one of the 6 participating sites which include 2 cardiac centers, the MHI and the IUCPQ, as well as 4 tertiary care centers, the Jewish General Hospital , the McGill University Health Centre and the CHUS.

Conditions

Timeline

Start date
2021-08-31
Primary completion
2025-12-31
Completion
2025-12-31
First posted
2021-03-10
Last updated
2024-11-22

Locations

6 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT04792281. Inclusion in this directory is not an endorsement.

Impact of FDG-PET/CT on Management of Patients with Native Valve Infective Endocarditis (NCT04792281) · Clinical Trials Directory